Literature DB >> 23927406

Differential effects of thapsigargin analogues on apoptosis of prostate cancer cells: complex regulation by intracellular calcium.

Charlotte Dubois1, Fabien Vanden Abeele, Pankaj Sehgal, Claus Olesen, Steffen Junker, Søren B Christensen, Natalia Prevarskaya, Jesper V Møller.   

Abstract

The inhibition of sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) by thapsigargin (Tg) and Tg-type analogues is considered to trigger cell death by activation of apoptotic pathways. Some of these analogues may be useful as antineoplastic agents after appropriate targeting as peptide conjugated prodrugs to cancer cells. With this in mind, this study evaluates the effect on LNCaP androgen-sensitive cancer cells of thapsigargin substituted with 12-aminododecanoyl linkers and Leu (Leu-8ADT), aspartate (Asp-8ADT) or Boc-8ADT. Our results show that both Leu-8ADT and Asp-8ADT result in rapid ER calcium depletion and an influx of calcium across the plasma membrane by activation of store-operated calcium entry. By contrast, ER Ca(2+) depletion by Boc-8ADT is a very slow process that does not perceptibly increase cytosolic Ca(2+) and activate store-operated calcium entry, because the inhibition of SERCA with this compound is very slow. Nevertheless, we find that Boc-8ADT is a more efficient inducer of apoptosis than both Tg and Leu-8ADT. Compared with Tg and the other analogues, apoptosis induced by Asp-8ADT is very modest, although this compound also activates store-operated calcium entry and at high concentrations (1 μm) causes severe morphological changes, reflecting decreased cell viability. We conclude that many factors need to be considered for optimization of these compounds in antineoplastic drug design. Among these ER stress induced by Ca(2+) endoplasmic reticulum mobilization seems particularly important, whereas the early cytosolic increase of Ca(2+) concentration preceding the executive phase of apoptosis appears to be of no, or little, consequence for a subsequent apoptotic effect.
© 2013 FEBS.

Entities:  

Keywords:  SERCA; apoptosis; calcium; prostate cancer; thapsigargin analogue

Mesh:

Substances:

Year:  2013        PMID: 23927406     DOI: 10.1111/febs.12475

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  16 in total

1.  Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca2+/Mn2+-transport ATPase (SPCA1a).

Authors:  Jialin Chen; Joren De Raeymaecker; Jannik Brøndsted Hovgaard; Susanne Smaardijk; Ilse Vandecaetsbeek; Frank Wuytack; Jesper Vuust Møller; Jan Eggermont; Marc De Maeyer; Søren Brøgger Christensen; Peter Vangheluwe
Journal:  J Biol Chem       Date:  2017-03-06       Impact factor: 5.157

Review 2.  Targeting thapsigargin towards tumors.

Authors:  Nhu Thi Quynh Doan; Eleonora Sandholdt Paulsen; Pankaj Sehgal; Jesper Vuust Møller; Poul Nissen; Samuel R Denmeade; John T Isaacs; Craig A Dionne; Søren Brøgger Christensen
Journal:  Steroids       Date:  2014-07-24       Impact factor: 2.668

3.  Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.

Authors:  Matteo Marchesini; Andrea Gherli; Anna Montanaro; Laura Patrizi; Claudia Sorrentino; Luca Pagliaro; Chiara Rompietti; Samuel Kitara; Sabine Heit; Claus E Olesen; Jesper V Møller; Monia Savi; Leonardo Bocchi; Rocchina Vilella; Federica Rizzi; Marilena Baglione; Giorgia Rastelli; Caterina Loiacono; Roberta La Starza; Cristina Mecucci; Kimberly Stegmaier; Franco Aversa; Donatella Stilli; Anne-Marie Lund Winther; Paolo Sportoletti; Maike Bublitz; William Dalby-Brown; Giovanni Roti
Journal:  Cell Chem Biol       Date:  2020-05-07       Impact factor: 8.116

4.  Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer.

Authors:  Sandeep Kumar; Ajay K Chaudhary; Rahul Kumar; Jordan O'Malley; Anna Dubrovska; Xinjiang Wang; Neelu Yadav; David W Goodrich; Dhyan Chandra
Journal:  Mol Oncol       Date:  2016-03-31       Impact factor: 6.603

5.  Interferon-β Inhibits Neurotrophin 3 Signalling and Pro-Survival Activity by Upregulating the Expression of Truncated TrkC-T1 Receptor.

Authors:  Simona Dedoni; Maria C Olianas; Angela Ingianni; Pierluigi Onali
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

6.  Inhibition of the sarco/endoplasmic reticulum (ER) Ca2+-ATPase by thapsigargin analogs induces cell death via ER Ca2+ depletion and the unfolded protein response.

Authors:  Pankaj Sehgal; Paula Szalai; Claus Olesen; Helle A Praetorius; Poul Nissen; Søren Brøgger Christensen; Nikolai Engedal; Jesper V Møller
Journal:  J Biol Chem       Date:  2017-09-29       Impact factor: 5.157

7.  Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells.

Authors:  Bo-Ra Lee; Sun-Young Chang; Eun-Hye Hong; Bo-Eun Kwon; Hong Min Kim; Yeon-Jeong Kim; Jongkook Lee; Hyun-Jong Cho; Jae-Hee Cheon; Hyun-Jeong Ko
Journal:  Oncotarget       Date:  2014-12-15

8.  SBF-1 exerts strong anticervical cancer effect through inducing endoplasmic reticulum stress-associated cell death via targeting sarco/endoplasmic reticulum Ca(2+)-ATPase 2.

Authors:  W Li; Z Ouyang; Q Zhang; L Wang; Y Shen; X Wu; Y Gu; Y Shu; B Yu; X Wu; Y Sun; Q Xu
Journal:  Cell Death Dis       Date:  2014-12-18       Impact factor: 8.469

9.  Targeting of short TRPM8 isoforms induces 4TM-TRPM8-dependent apoptosis in prostate cancer cells.

Authors:  Gabriel Bidaux; Anne-Sophie Borowiec; Charlotte Dubois; Philippe Delcourt; Céline Schulz; Fabien Vanden Abeele; Gilbert Lepage; Emilie Desruelles; Alexandre Bokhobza; Etienne Dewailly; Christian Slomianny; Morad Roudbaraki; Laurent Héliot; Jean-Louis Bonnal; Brigitte Mauroy; Pascal Mariot; Loïc Lemonnier; Natalia Prevarskaya
Journal:  Oncotarget       Date:  2016-05-17

Review 10.  Role of endoplasmic reticulum stress in drug-induced toxicity.

Authors:  Fabienne Foufelle; Bernard Fromenty
Journal:  Pharmacol Res Perspect       Date:  2016-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.